These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 3934648

  • 1. Lack of effect of thyrotropin releasing hormone (TRH) in circulatory shock.
    Hock CE, Lefer AM.
    Peptides; 1985; 6(3):547-53. PubMed ID: 3934648
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Beneficial effect of anisodamine in hemorrhagic shock.
    Su J, Hock CE, Lefer AM.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Apr; 325(4):360-5. PubMed ID: 6728045
    [Abstract] [Full Text] [Related]

  • 4. Role of AVP in maintenance of circulatory homeostasis during hemorrhagic shock.
    Hock CE, Su JY, Lefer AM.
    Am J Physiol; 1984 Feb; 246(2 Pt 2):H174-9. PubMed ID: 6696129
    [Abstract] [Full Text] [Related]

  • 5. Beneficial actions of thromboxane receptor antagonism in hemorrhagic shock.
    Bitterman H, Yanagisawa A, Lefer AM.
    Circ Shock; 1986 Feb; 20(1):1-11. PubMed ID: 2945667
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Thyrotropin-releasing hormone increases survival in canine hemorrhagic shock.
    Sugiura A, Smith RA, Shatney CH.
    J Surg Res; 1986 Jan; 40(1):63-8. PubMed ID: 3079847
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Beneficial effect of arachidonic acid during hemorrhagic shock in the dog.
    Flynn JT, Lefer AM.
    Circ Res; 1977 Apr; 40(4):422-8. PubMed ID: 844155
    [Abstract] [Full Text] [Related]

  • 11. Beneficial mechanisms of action of a prostacyclin enhancing agent in splanchnic artery occlusion shock.
    Aoki N, Siegfried M, Tsao P, Lento P, Lefer AM.
    Res Commun Chem Pathol Pharmacol; 1988 Jun; 60(3):275-89. PubMed ID: 3175328
    [Abstract] [Full Text] [Related]

  • 12. [Beneficial effect of thyrotropin-releasing hormone in combination with HSD on hemorrhagic shock with pulmonary edema at high altitude in the rat].
    Hu DY, Liu LM, Li P, Liu JC, Liu HD, He YM, Huo XP, Tian KL, Shi QG, Xiao N, Zhou XW.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 May; 15(5):268-71. PubMed ID: 12837184
    [Abstract] [Full Text] [Related]

  • 13. Action of thyrotropin-releasing hormone in experimental hemorrhagic shock--cardiovascular mechanism.
    Zheng D, Chen HS, Hu DY.
    J Tongji Med Univ; 1990 May; 10(3):187-92. PubMed ID: 1979356
    [Abstract] [Full Text] [Related]

  • 14. Naloxone and TRH in the treatment of shock and trauma: what future roles?
    Bernton EW.
    Ann Emerg Med; 1985 Aug; 14(8):729-35. PubMed ID: 3927793
    [Abstract] [Full Text] [Related]

  • 15. The thyrotropin releasing hormone analogue, RGH 2202, reverses experimental haemorrhagic shock in rats.
    Coppi G, Falcone A.
    Eur J Pharmacol; 1990 Jun 21; 182(1):185-8. PubMed ID: 2119310
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Salutary effects of CG-4203, a novel, stable prostacyclin analog, in hemorrhagic shock.
    Bitterman H, Smith BA, Lefer DJ, Lefer AM.
    J Cardiovasc Pharmacol; 1988 Sep 21; 12(3):293-9. PubMed ID: 2464101
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Protective effect of thyrotropin-releasing hormone against lipid peroxidation injury during traumatic shock in rats].
    Chen H.
    Zhonghua Yi Xue Za Zhi; 1991 Aug 21; 71(8):438-40, 32. PubMed ID: 1660763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.